
LAVA Medtech Acquisition
LVAC | NASDAQ
$10.43
$0.00 (0.00%)
At close: May 10, 2023, 03:30 PM ET
LAVA Medtech Acquisition Company Profile
Company profile explainedCompany Profile
LAVA Medtech Acquisition Corp. (LVAC) currently lacks significant standalone operations. Its primary objective is to secure businesses or assets through various strategic transactions, including mergers, capital stock exchanges, asset acquisitions, stock purchases, or corporate reorganizations. The firm's strategic focus is directed towards opportunities within the healthcare and allied industries. Established in 2021, the company is based in Waltham, Massachusetts, and operates as a subsidiary of LAVA Medtech Sponsor LP.
Key Executives
| Name | Position |
|---|---|
| Vasco Larcina | Chief Financial Officer |
LAVA Medtech Acquisition

| Country | United States |
| IPO Date | Dec 17, 2021 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Anthony Natale |
Stock Details
| Ticker Symbol | LVAC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001855450 |
| CUSIP Number | 519345102 |
| ISIN Number | n/a |
| SIC Code | 6770 |
Add to Watchlist
Select watchlists to add or remove LVAC